Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

October 2016; Volume 36,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Aburatani, HIROYUKI

    1. You have access
      Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma
      TAKUMA HAYASHI, MIKI KAWANO, TOMOYUKI ICHIMURA, KOICHI IDA, HIROFUMI ANDO, DORIT ZHARHARY, YAE KANAI, HIROYUKI ABURATANI, SUSUMU TONEGAWA, TANRI SHIOZAWA, NOBUO YAEGASHI and IKUO KONISHI
      Anticancer Research October 2016, 36 (10) 4997-5007;
  2. Adenis, ANTOINE

    1. You have access
      Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma
      NATHALIE LEMOINE, ANTOINE ADENIS, OLIVIER BOUCHE, ALAIN DUHAMEL, ALEXANDRA HEURGUE, EMMANUELLE LETEURTRE, ERIC AMELA, JULIA SALLERON and MOHAMED HEBBAR
      Anticancer Research October 2016, 36 (10) 5543-5549;
  3. Aizawa, TAKUYA

    1. You have access
      Radiation Pneumonitis Changes over Time after Stereotactic Body Radiation Therapy for Lung Tumors: Post-treatment Cavity (Sunny-side-up Egg-like) Changes
      TOSHIYA MAEBAYASHI, NAOYA ISHIBASHI, TAKUYA AIZAWA, MASAKUNI SAKAGUCHI, TSUTOMU SATO, JIRO KAWAMORI and YOSHIAKI TANAKA
      Anticancer Research October 2016, 36 (10) 5563-5570;
    2. You have access
      Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy
      MASAKUNI SAKAGUCHI, TOSHIYA MAEBAYASHI, TAKUYA AIZAWA, NAOYA ISHIBASHI and TSUTOMU SAITO
      Anticancer Research October 2016, 36 (10) 5519-5525;
  4. Alajez, NEHAD M.

    1. You have access
      Runt-related Transcription Factor 1 (RUNX1T1) Suppresses Colorectal Cancer Cells Through Regulation of Cell Proliferation and Chemotherapeutic Drug Resistance
      MUSAAD ALFAYEZ, RADHAKRISHNAN VISHNUBALAJI and NEHAD M. ALAJEZ
      Anticancer Research October 2016, 36 (10) 5257-5263;
  5. Alberts, LEONIE

    1. You have access
      Post-treatment Surveillance for Stage I and II Non-small Cell Lung Cancer: Impact on Clinical Outcome
      RENATA KARZIJN, LEONIE ALBERTS, JOHANNES C. KELDER, FREDERIK N. HOFMAN, SHERIF Y. EL. SHAROUNI, ELISABETH A. KASTELIJN and FRANZ M.N.H. SCHRAMEL
      Anticancer Research October 2016, 36 (10) 5413-5418;
  6. Alfayez, MUSAAD

    1. You have access
      Runt-related Transcription Factor 1 (RUNX1T1) Suppresses Colorectal Cancer Cells Through Regulation of Cell Proliferation and Chemotherapeutic Drug Resistance
      MUSAAD ALFAYEZ, RADHAKRISHNAN VISHNUBALAJI and NEHAD M. ALAJEZ
      Anticancer Research October 2016, 36 (10) 5257-5263;
  7. Alt, MARIE

    1. You have access
      Bevacizumab Associated with Chemotherapy for Initially Non-resectable Liver Metastases from Colorectal Cancer: a Case–Control Study
      MARIE ALT, STÉPHANIE TRUANT, THIBAUT RENAUD-VANTROYS, CÉDRIC SÉQUIER, ALAIN DUHAMEL, MEHDI EL AMRANY, ANTHONY TURPIN, SAMIRA MAKHLOUFI, FRANÇOIS RENÉ PRUVOT and MOHAMED HEBBAR
      Anticancer Research October 2016, 36 (10) 5551-5555;
  8. Altan, BOLAG

    1. You have access
      High Expression of MRE11–RAD50–NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer
      BOLAG ALTAN, TAKEHIKO YOKOBORI, MUNENORI IDE, TUYA BAI, TORU YANOMA, AKIHARU KIMURA, NORIMICHI KOGURE, MASAKI SUZUKI, PINJIE BAO, ERITO MOCHIKI, KYOICHI OGATA, TADASHI HANDA, KYOICHI KAIRA, MASAHIKO NISHIYAMA, TAKAYUKI ASAO, TETSUNARI OYAMA and HIROYUKI KUWANO
      Anticancer Research October 2016, 36 (10) 5237-5247;
  9. Amano, RYOSUKE

    1. You have access
      Prognostic Significance of MicroRNA-21 Expression in Patients with Unresectable Metastatic Colon Cancer
      YASUHITO ISEKI, MASATSUNE SHIBUTANI, KIYOSHI MAEDA, HISASHI NAGAHARA, TATSUNARI FUKUOKA, TETSURO IKEYA, SHINJI MATSUTANI, KENJIRO KIMURA, TAKAHIRO TOYOKAWA, RYOSUKE AMANO, HIROAKI TANAKA, KAZUYA MUGURUMA, KOSEI HIRAKAWA and MASAICHI OHIRA
      Anticancer Research October 2016, 36 (10) 5145-5151;
  10. Amant, FREDERIC

    1. You have access
      Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma
      MARTIN KOSKAS, JEROEN DEPREEUW, STIJN MOENS, DANIELA ANNIBALI, TINE CUPPENS, PHILIPPE MOERMAN, DIETHER LAMBRECHTS and FREDERIC AMANT
      Anticancer Research October 2016, 36 (10) 5381-5384;
« Previous (Pages : 1 2 3 4 5 6 ... 57) Next »
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 36, Issue 10
October 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire